SKI Market

Indian Indices

Sensex

85,041.45 -367.25
( -0.43%)

Global Indices

Nasdaq

48,728.27 -23.90
(-0.05%)

Dow Jones

6,949.98 -3.07
(-0.04%)

Hang Seng

50,641.54 233.75
(0.46%)

Nikkei 225

9,870.68 -18.54
(-0.19%)

Forex

USD-INR

89.83 0.26
(0.29%)

EUR-INR

105.77 0.25
(0.24%)

GBP-INR

121.29 0.43
(0.36%)

JPY-INR

0.58 0.00
(0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

578.2640535

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

67.83

170514.45

EPS(TTM)

Face Value()

Div & Yield %

94.7

0.47

Back

Divi's Laboratories standalone net profit rises 34.36% in the September 2025 quarter

Nov 07,2025

Net profit of Divi's Laboratories rose 34.36% to Rs 696.00 crore in the quarter ended September 2025 as against Rs 518.00 crore during the previous quarter ended September 2024. Sales rose 15.55% to Rs 2660.00 crore in the quarter ended September 2025 as against Rs 2302.00 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	2660.00	2302.00	16
OPM %	33.65	31.67	-
PBDT	1033.00	833.00	24
PBT	920.00	735.00	25
NP	696.00	518.00	34

85,041.45 -367.25 ( -0.43%)

48,728.27 -23.90 (-0.05%)

6,949.98 -3.07 (-0.04%)

50,641.54 233.75 (0.46%)

9,870.68 -18.54 (-0.19%)

89.83 0.26 (0.29%)

105.77 0.25 (0.24%)

121.29 0.43 (0.36%)

0.58 0.00 (0.43%)